Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES Share Price    (DIVI)

Here is the latest stock price and chart of Divis Laboratories. For more details, see the Divis Laboratories company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since large caps interest you, here's our guide to buying bluechip stocks.

Watch Now: A Massive 15x Opportunity in Electric Vehicles

REFRESH
Live BSE Quotes Oct 25, 2021 (Close)
Price (Rs)4,996.80 Open (Rs) 5,040.00 High (Rs) 5,067.40 Low (Rs) 4,875.85
% Change-1.71 Volume 24,022 Value (Rs) 118,701,397 52-Week H/L 5,425.00 / 3,021.95
Live NSE Quotes Oct 25, 2021 (Close)
Price (Rs)4,995.95 Open (Rs) 5,052.00 High (Rs) 5,070.00 Low (Rs) 4,874.85
% Change-1.53 Volume 588,823 Value (Rs) 2,918,232,240 52-Week H/L 5,425.10 / 3,020.10
Change
1 Day
-1.71%
1 Month
1.28%
3 Months
1.54%
1 Year
64.31%
5 Years (CAGR)*
31.36%
10 Years (CAGR)*
30.09%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 77.20 P/E Ratio (x) 64.73 Market Cap (Rs m) 1,326,493.50 P/BV (x) 14.27 Dividend Yield (%) 0.40
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

DIVIS LABORATORIES Share Price Today:

DIVIS LABORATORIES last traded price was down 1.7% to Rs 4,996.8 on the BSE. On the NSE, DIVIS LABORATORIES last traded price was down 1.5% to Rs 4,996.0. The total volume of shares traded was 0.6 m.

Overall, the broader S&P BSE HEALTHCARE Index was down by 0.1%. And the benchmark S&P BSE SENSEX was at 60,967.1 (up 0.2%).

Over the last 30 days, the DIVIS LABORATORIES share price is down 2.9%. And over the last one year, DIVIS LABORATORIES share price is up 61.9%.

The current market capitalisation of DIVIS LABORATORIES stands at Rs 1,326,493.50 m. For more information, check out the list of top 100 companies in India in terms of market cap.

As of September 2021, company promoters held 51.95% stake in DIVIS LABORATORIES, with no shares having been pledged. To know more, check out the latest shareholding pattern of DIVIS LABORATORIES.


What else is happening in the markets today? Dig in...


Today's Market

Tech Mahindra Quarterly Results, Tata Power's Milestone of 1,000 EV Charging Stations, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a positive note yesterday. Benchmark indices snapped their 4-day losing streak, led by gains in index heavyweights ICICI Bank, ONGC and Axis Bank.

Related Views On News

DIVIS LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of DIVIS LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.2% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, DIVIS LABORATORIES has posted a net profit of Rs 6 bn (up 13.2% YoY). Sales on the other hand came in at Rs 20 bn (up 13.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY21); Net Profit Up 29.3% (Quarterly Result Update)

Jun 28, 2021 | Updated on Jun 28, 2021

For the quarter ended March 2021, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 29.3% YoY). Sales on the other hand came in at Rs 18 bn (up 28.7% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

5 Green Energy Stocks to Watch as India Readies for a Revolution (Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You... (Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Tata Group Stocks are on Fire: Which one Should You Buy? (Profit Hunter)

Oct 15, 2021

Tata group stocks are on fire. Find out which one deserves your attention.

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally (Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

India's Big PSU Selloff: Watch Out for these Top Stocks (Views On News)

Oct 15, 2021

The government's plan to divest its stakes in PSUs could spark off a rally in these four stocks.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 5-YR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS